{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:23:11Z","timestamp":1791084191323,"version":"4.1.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.semcancer.2021.07.013","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T02:25:56Z","timestamp":1626920756000},"page":"1179-1189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"P2","title":["Microbes in gynecologic cancers: Causes or consequences and therapeutic potential"],"prefix":"10.1016","volume":"86","author":[{"given":"Mohd","family":"Wahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-8701","authenticated-orcid":false,"given":"Sajad A.","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju Kumar","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2011-0955","authenticated-orcid":false,"given":"Naseem","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudisha","family":"Jogaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6938-619X","authenticated-orcid":false,"given":"Ashutosh Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandeep","family":"Rattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.semcancer.2021.07.013_bib0005","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00203-020-01931-x","article-title":"Human microbiome: an academic update on human body site specific surveillance and its possible role","volume":"202","author":"Dekaboruah","year":"2020","journal-title":"Arch. Microbiol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0010","first-page":"743","article-title":"Vaginal microbiomes and ovarian cancer: a review","volume":"10","author":"Xu","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2015.04.036","article-title":"The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment","volume":"138","author":"Chase","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41585-020-0286-z","article-title":"The microbiome and gynaecological cancer development, prevention and therapy","volume":"17","author":"Laniewski","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"Suppl 1","key":"10.1016\/j.semcancer.2021.07.013_bib0025","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12866-021-02152-y","article-title":"Distinction between vaginal and cervical microbiota in high-risk human papilloma virus-infected women in China","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Microbiol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030714","article-title":"HPV and other microbiota; who\u2019s good and who\u2019s bad: effects of the microbial environment on the development of cervical cancer-a non-systematic review","volume":"10","author":"Lasche","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0040","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1038\/s41598-018-25879-7","article-title":"Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women","volume":"8","author":"Laniewski","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0045","first-page":"444","article-title":"Original site of cervical carcinoma; topographical relationship of carcinoma of the cervix to the external os and to the squamocolumnar junction","volume":"7","author":"Marsh","year":"1956","journal-title":"Obstet. Gynecol."},{"issue":"26","key":"10.1016\/j.semcancer.2021.07.013_bib0050","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1073\/pnas.1202684109","article-title":"A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer","volume":"109","author":"Herfs","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0055","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"10.1016\/j.semcancer.2021.07.013_bib0060","doi-asserted-by":"crossref","first-page":"36225","DOI":"10.18632\/oncotarget.16717","article-title":"The ovarian cancer oncobiome","volume":"8","author":"Banerjee","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1996.0316","article-title":"Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA","volume":"63","author":"Chan","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fonc.2020.00163","article-title":"Opportunities and challenges of the human microbiome in ovarian cancer","volume":"10","author":"Cheng","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40168-018-0483-7","article-title":"Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies","volume":"6","author":"Panebianco","year":"2018","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/aji.12264","article-title":"Bacterial vaginosis and the cervicovaginal immune response","volume":"71","author":"Mitchell","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.07.013_bib0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.it.2018.09.007","article-title":"The impact of intratumoral and gastrointestinal microbiota on systemic cancer therapy","volume":"39","author":"Cogdill","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-3-030-16391-4_10","article-title":"Human microbiota and personalized cancer treatments: role of commensal microbes in treatment outcomes for cancer patients","volume":"178","author":"Gately","year":"2019","journal-title":"Cancer Treat. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.micinf.2008.01.004","article-title":"Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis","volume":"10","author":"Libby","year":"2008","journal-title":"Microbes Infect."},{"issue":"12","key":"10.1016\/j.semcancer.2021.07.013_bib0100","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","article-title":"Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner","volume":"209","author":"Doerflinger","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0105","first-page":"30261","article-title":"Inflammation is a key contributor to ovarian cancer cell seeding","volume":"8","author":"Dongyu Jia","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.17772\/gp\/1579","article-title":"Inflammation and ovarian cancer--current views","volume":"84","author":"Kisielewski","year":"2013","journal-title":"Ginekol. Pol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.idc.2013.08.004","article-title":"Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment","volume":"27","author":"Mitchell","year":"2013","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0120","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.chom.2013.05.010","article-title":"Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response","volume":"13","author":"Chumduri","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13027-017-0134-9","article-title":"The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis","volume":"12","author":"Ingerslev","year":"2017","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4939-8751-1_3","article-title":"Role of microbiome in carcinogenesis process and epigenetic regulation of colorectal cancer","volume":"1856","author":"Farhana","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.013_bib0140","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gutjnl-2019-318556","article-title":"International cancer microbiome consortium consensus statement on the role of the human microbiome in carcinogenesis","volume":"68","author":"Scott","year":"2019","journal-title":"Gut."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0145","first-page":"326","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1471-0528.14631","article-title":"The role of the vaginal microbiome in gynaecological cancer","volume":"125","author":"Champer","year":"2018","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0155","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41598-018-38031-2","article-title":"The biodiversity composition of microbiome in ovarian carcinoma patients","volume":"9","author":"Zhou","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.013_bib0160","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/jog.13701","article-title":"Case for a role of the microbiome in gynecologic cancers: clinician\u2019s perspective","volume":"44","author":"Mert","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/carcin\/bgt392","article-title":"Emerging roles of the microbiome in cancer","volume":"35","author":"Bultman","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fphar.2019.00484","article-title":"Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease","volume":"10","author":"Tanja Sarenac","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0175","doi-asserted-by":"crossref","first-page":"3257939","DOI":"10.1155\/2019\/3257939","article-title":"Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives","volume":"2019","author":"Chan","year":"2019","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0180","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.3802\/jgo.2016.27.e43","article-title":"Advances in diagnosis and treatment of metastatic cervical cancer","volume":"27","author":"Li","year":"2016","journal-title":"J. Gynecol. Oncol."},{"issue":"31","key":"10.1016\/j.semcancer.2021.07.013_bib0185","doi-asserted-by":"crossref","first-page":"51840","DOI":"10.18632\/oncotarget.16025","article-title":"Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fimmu.2018.00208","article-title":"Uterine microbiota: residents, tourists, or invaders?","volume":"9","author":"Baker","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.07.013_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080074","article-title":"Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota","volume":"8","author":"O\u2019Hanlon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0200","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-018-0418-3","article-title":"The implausible \u201cin vivo\u201d role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota","volume":"6","author":"Tachedjian","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0205","series-title":"Encyclopedia of Reproduction","author":"\u0141aniewski","year":"2018"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12866-016-0663-1","article-title":"Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman","volume":"16","author":"Maldonado-Barragan","year":"2016","journal-title":"BMC Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00203-019-01747-4","article-title":"Cervical cancer and vaginal microbiota changes","volume":"202","author":"Kovachev","year":"2020","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0220","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1038\/srep16865","article-title":"Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity","volume":"5","author":"Mitra","year":"2015","journal-title":"Sci. Rep."},{"issue":"6230","key":"10.1016\/j.semcancer.2021.07.013_bib0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.semcancer.2021.07.013_bib0230","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","article-title":"Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance","volume":"20","author":"Insinga","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0240","first-page":"7035","article-title":"Microbiota dysbiosis is associated with HPV-induced cervical carcinogenesis","volume":"16","author":"Kwasniewski","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1471-0528.15854","article-title":"The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis","volume":"127","author":"Norenhag","year":"2020","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","article-title":"Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis","volume":"221","author":"Brusselaers","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0255","doi-asserted-by":"crossref","first-page":"e1008376","DOI":"10.1371\/journal.ppat.1008376","article-title":"Costa Rica HPV Vaccine Trial (CVT) Group. Cervicovaginal microbiome and natural history of HPV in a longitudinal study","volume":"16","author":"Usyk","year":"2020","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0260","doi-asserted-by":"crossref","first-page":"e63514","DOI":"10.1371\/journal.pone.0063514","article-title":"Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"issue":"9590","key":"10.1016\/j.semcancer.2021.07.013_bib0265","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet."},{"issue":"20","key":"10.1016\/j.semcancer.2021.07.013_bib0270","article-title":"Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections","volume":"2","author":"Torcia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fmed.2018.00181","article-title":"The vaginal microenvironment: the physiologic role of lactobacilli","volume":"5","author":"Amabebe","year":"2018","journal-title":"Front Med (Lausanne)."},{"issue":"Pt 4","key":"10.1016\/j.semcancer.2021.07.013_bib0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1099\/jmm.0.000042","article-title":"Patterns of Candida biofilm on intrauterine devices","volume":"64","author":"Zahran","year":"2015","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/13693780902856626","article-title":"Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis","volume":"48","author":"Auler","year":"2010","journal-title":"Med. Mycol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0290","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/1040841X.2017.1291579","article-title":"Etiology of bacterial vaginosis and polymicrobial biofilm formation","volume":"43","author":"Jung","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0295","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.trsl.2016.07.004","article-title":"Does the vaginal microbiota play a role in the development of cervical cancer?","volume":"179","author":"Maria Kyrgiou","year":"2017","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.013_bib0300","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/infdis\/jiu231","article-title":"Human alpha-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus","volume":"210","author":"Spear","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"3 Suppl 2","key":"10.1016\/j.semcancer.2021.07.013_bib0305","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","article-title":"Natural history and epidemiology of HPV infection and cervical cancer","volume":"110","author":"Castellsague","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0310","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/1471-2334-14-471","article-title":"Association between cigarette smoking and the vaginal microbiota: a pilot study","volume":"14","author":"Brotman","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.013_bib0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.OLQ.0000129948.91055.9F","article-title":"Predictors of bacterial vaginosis in adolescent women who douche","volume":"31","author":"Schwebke","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0320","doi-asserted-by":"crossref","first-page":"103165","DOI":"10.1016\/j.critrevonc.2020.103165","article-title":"The gut microbiome and cancer immunotherapeutics: a review of emerging data and implications for future gynecologic cancer research","volume":"157","author":"McKenzie","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0325","series-title":"Everything You Need to Know About Dysplasia","author":"Johnson","year":"2018"},{"issue":"Suppl 1","key":"10.1016\/j.semcancer.2021.07.013_bib0330","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1093\/infdis\/jiw184","article-title":"The vaginal microbiome: current understanding and future directions","volume":"214","author":"Martin","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.013_bib0335","doi-asserted-by":"crossref","first-page":"e105998","DOI":"10.1371\/journal.pone.0105998","article-title":"The vaginal microbiota: what have we learned after a decade of molecular characterization?","volume":"9","author":"van de Wijgert","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0340","first-page":"1","article-title":"Microbiome and cervical Cancer","author":"Castanheira","year":"2020","journal-title":"Pathobiology."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0345","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/CEJ.0b013e328355ed23","article-title":"Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study","volume":"22","author":"Verhoeven","year":"2013","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13048-020-00668-x","article-title":"Anti-tumor activities of probiotics in cervical cancer","volume":"13","author":"Jahanshahi","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0355","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1440-1711.2000.00886.x","article-title":"Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp","volume":"78","author":"Kailasapathy","year":"2000","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/1040841X.2016.1179622","article-title":"Cellular and molecular effects of yeast probiotics on cancer","volume":"43","author":"Saber","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0365","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050521","article-title":"Antioxidant properties of probiotic Bacteria","volume":"9","author":"Wang","year":"2017","journal-title":"Nutrients."},{"issue":"11","key":"10.1016\/j.semcancer.2021.07.013_bib0370","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1017\/S0007114511004934","article-title":"Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue","volume":"107","author":"Chen","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0375","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7030066","article-title":"Probiotics and colon cancer","volume":"7","author":"Drago","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0380","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3389\/fmicb.2019.02185","article-title":"Probiotic Bacillus Attenuates oxidative stress- induced intestinal injury via p38-Mediated autophagy","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12602-017-9339-x","article-title":"Inhibitory effect of vaginal Lactobacillus supernatants on cervical Cancer cells","volume":"10","author":"Wang","year":"2018","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0390","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000478994","article-title":"Influence of orally administered probiotic Lactobacillus strains on vaginal microbiota in women with breast Cancer during chemotherapy: a randomized placebo-controlled double-blinded pilot study","volume":"12","author":"Marschalek","year":"2017","journal-title":"Breast Care Basel (Basel)"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0395","unstructured":"Corpus uteri. 2020."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0400","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"10023","key":"10.1016\/j.semcancer.2021.07.013_bib0405","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.013_bib0410","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1055-9965.EPI-18-0264","article-title":"Cancer progress and priorities: uterine cancer","volume":"27","author":"Felix","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0415","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/0284186X.2018.1540886","article-title":"The role of biomarkers in endometrial cancer and hyperplasia: a literature review","volume":"58","author":"Hutt","year":"2019","journal-title":"Acta Oncol. (Madr)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0420","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13073-016-0368-y","article-title":"Potential contribution of the uterine microbiome in the development of endometrial cancer","volume":"8","author":"Walther-Antonio","year":"2016","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0425","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040593","article-title":"New opportunities for endometrial health by modifying uterine microbial composition: present or future?","volume":"10","author":"Molina","year":"2020","journal-title":"Biomolecules"},{"issue":"110203","key":"10.1016\/j.semcancer.2021.07.013_bib0430","article-title":"Adele Balouchi Association between the microbiota and women\u2019s cancers \u2013 cause or consequences?","volume":"127","author":"Negin Alizadehmohajer","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/aje\/kwi243","article-title":"A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease","volume":"162","author":"Ness","year":"2005","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0440","first-page":"1581","article-title":"Barcoded sequencing reveals diverse intrauterine microbiomes in patients suffering with endometrial polyps","volume":"8","author":"Fang","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0445","article-title":"Microbiome profile of deep endometriosis patients: comparison of vaginal fluid, endometrium and lesion","volume":"10","author":"Hernandes","year":"2020","journal-title":"Diagnostics Basel (Basel)"},{"issue":"36","key":"10.1016\/j.semcancer.2021.07.013_bib0450","article-title":"Reproductive microbiomes: using the microbiome as a novel diagnostic tool for endometriosis","volume":"2","author":"Melissa","year":"2021","journal-title":"Reprod. Immunol. Open Access"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0455","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejogrb.2016.01.040","article-title":"Molecular detection of intrauterine microbial colonization in women with endometriosis","volume":"199","author":"Khan","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0460","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41467-017-00901-0","article-title":"The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.013_bib0465","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giy107","article-title":"The metagenome of the female upper reproductive tract","volume":"7","author":"Li","year":"2018","journal-title":"Gigascience."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0470","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10482-017-0992-6","article-title":"A role for the endometrial microbiome in dysfunctional menstrual bleeding","volume":"111","author":"Pelzer","year":"2018","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0475","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1038\/s41598-019-55720-8","article-title":"Postmenopause as a key factor in the composition of the Endometrial Cancer microbiome (ECbiome)","volume":"9","author":"Walsh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0480","doi-asserted-by":"crossref","first-page":"9905","DOI":"10.1038\/s41598-019-46173-0","article-title":"Does the endometrial cavity have a molecular microbial signature?","volume":"9","author":"Winters","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/LGT.0b013e31823c79c4","article-title":"Correlation of Atopobium vaginae amount with bacterial vaginosis markers","volume":"16","author":"Marconi","year":"2012","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0490","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2019.00114","article-title":"Selection of new probiotics for endometrial health","volume":"9","author":"Chenoll","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0495","doi-asserted-by":"crossref","first-page":"e56111","DOI":"10.1371\/journal.pone.0056111","article-title":"A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease","volume":"8","author":"Yeoman","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0500","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00404-013-3064-9","article-title":"The role of lactobacilli and probiotics in maintaining vaginal health","volume":"289","author":"Borges","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.013_bib0505","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10080251","article-title":"The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer","volume":"10","author":"Savant","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0510","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0515","series-title":"American Cancer Society","first-page":"2020","author":"Cancer Facts & Figures","year":"2020"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0520","series-title":"What Is the Global Prevalence of Ovarian Cancer","author":"Andrew","year":"2020"},{"issue":"12","key":"10.1016\/j.semcancer.2021.07.013_bib0525","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1016\/S1470-2045(17)30834-3","article-title":"Possible origin of ovarian cancer in the fallopian tubes","volume":"18","author":"Venkatesan","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0530","series-title":"Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ\u00ae)\u2013Patient Version","year":"2021"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0535","series-title":"117: Gynecologic Malignancies. Harrison\u2019s Principles of Internal Medicine","author":"Dennis Kasper","year":"2021"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0540","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0545","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13046-018-0854-8","article-title":"RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression","volume":"37","author":"Liu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0550","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.2147\/CMAR.S265205","article-title":"Changes of intestinal microbiota in ovarian Cancer patients treated with surgery and chemotherapy","volume":"12","author":"Tong","year":"2020","journal-title":"Cancer Manage. Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0555","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/cti.2017.6","article-title":"Microbiome effects on immunity, health and disease in the lung","volume":"6","author":"Shukla","year":"2017","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0560","series-title":"What Are the Early Signs of Ovarian Cancer and How Do You Detect Them?","year":"2021"},{"issue":"11","key":"10.1016\/j.semcancer.2021.07.013_bib0565","first-page":"1201","article-title":"Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women\u2019s Health Initiative Observational Study","volume":"30","author":"Trabert","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"12","key":"10.1016\/j.semcancer.2021.07.013_bib0570","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1210\/jc.2014-2222","article-title":"Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women","volume":"99","author":"Fuhrman","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0575","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12282-016-0734-z","article-title":"Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications","volume":"24","author":"Yang","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0580","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0585","doi-asserted-by":"crossref","first-page":"1603758","DOI":"10.1155\/2019\/1603758","article-title":"Cutting edge: probiotics and fecal microbiota transplantation in Immunomodulation","volume":"2019","author":"Zeng","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0590","first-page":"257","article-title":"Prashant Purohit. Synchronous occurrence of brucellosis and ovarian cancer - a case report","volume":"6","author":"Maha Mohamed Emara","year":"2007","journal-title":"Austral - Asian J. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.013_bib0595","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","article-title":"Viral and bacterial aetiologies of epithelial ovarian cancer","volume":"31","author":"Shanmughapriya","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0600","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djy084","article-title":"Antibodies against Chlamydia trachomatis and ovarian Cancer risk in two independent populations","volume":"111","author":"Trabert","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0605","doi-asserted-by":"crossref","first-page":"412","DOI":"10.20344\/amp.7706","article-title":"Endometrial tuberculosis simulating an ovarian cancer: a case report","volume":"29","author":"Di Giovanni","year":"2016","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0610","first-page":"1171","article-title":"Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study","author":"Nuno","year":"2019","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.013_bib0615","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0620","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2020.08.027","article-title":"Diet and gut microbiome interactions in gynecologic cancer","volume":"159","author":"AlHilli","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0625","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.mehy.2008.06.028","article-title":"Is chlamydia-infected tubal fimbria the origin of ovarian cancer?","volume":"71","author":"Jesus Paula Carvalho","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0630","doi-asserted-by":"crossref","first-page":"824627","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"9980","key":"10.1016\/j.semcancer.2021.07.013_bib0635","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.013_bib0640","first-page":"1","article-title":"The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ","volume":"13","author":"Wang","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0645","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00280-019-03988-y","article-title":"Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)","volume":"85","author":"Kashani","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.013_bib0650","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.013_bib0655","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","article-title":"Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism","volume":"8","author":"Gao","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0665","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0670","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s10020-021-00295-2","article-title":"The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling","volume":"27","author":"Sipos","year":"2021","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0675","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/AOG.0000000000000171","article-title":"Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population","volume":"123","author":"Sinno","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0680","series-title":"Vaginal Cancer 2109","author":"Staff MC","year":"2021"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0685","series-title":"About Vaginal Cancer","author":"team TACSmaec","year":"2018"},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0690","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9378(77)90445-8","article-title":"Carcinoma of vagina 10 or more years following pelvic irradiation therapy","volume":"127","author":"Pride","year":"1977","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.013_bib0695","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0002-9343(86)90358-X","article-title":"Diethylstilbestrol and clear cell vaginal carcinoma. Reappraisal of the epidemiologic evidence","volume":"81","author":"McFarlane","year":"1986","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0700","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1038\/s41598-019-55720-8","article-title":"Postmenopause as a key factor in the composition of the Endometrial Cancer microbiome (ECbiome)","volume":"9","author":"Dana","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0705","unstructured":"ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. United States [Available from: https:\/\/www.clinicaltrials.gov\/."},{"issue":"21","key":"10.1016\/j.semcancer.2021.07.013_bib0710","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.21037\/atm-20-622","article-title":"Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study","volume":"8","author":"Zhou","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0715","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/modpathol.2016.197","article-title":"Biological relevance of human papillomaviruses in vulvar cancer","volume":"30","author":"Halec","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0720","series-title":"Cancer Facts & Figures","author":"Key Statistics for Vulvar Cancer","year":"2021"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0725","series-title":"Vulval Cancer","year":"2018"},{"key":"10.1016\/j.semcancer.2021.07.013_bib0730","series-title":"Vulvar Cancer","author":"Ratini","year":"2020"},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0735","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/modpathol.3801009","article-title":"Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma","volume":"21","author":"de Koning","year":"2008","journal-title":"Mod. Pathol."},{"issue":"15","key":"10.1016\/j.semcancer.2021.07.013_bib0740","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1158\/1078-0432.CCR-16-3230","article-title":"Vulvar squamous cell carcinoma (VSCC) as two diseases: HPV status identifies distinct mutational profiles including oncogenic fibroblast growth factor receptor 3","volume":"23","author":"Weberpals","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0745","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004347-199104000-00001","article-title":"Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction","volume":"10","author":"Toki","year":"1991","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0750","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-8258(91)90035-4","article-title":"Correlation of histology and detection of human papillomavirus DNA in vulvar cancers","volume":"43","author":"Nuovo","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.013_bib0755","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0046-8177(91)90294-Y","article-title":"Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology","volume":"22","author":"Bloss","year":"1991","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0760","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.2910550310","article-title":"Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: a search for a possible impact of HPV on vulvar cancer prognosis","volume":"55","author":"Hording","year":"1993","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.013_bib0765","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","article-title":"Exploring the emerging role of the microbiome in cancer immunotherapy","volume":"7","author":"Fessler","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0770","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","article-title":"Microbiome and anticancer immunosurveillance","volume":"165","author":"Zitvogel","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.013_bib0775","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.013_bib0780","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2014.12.004","article-title":"Targeting T cell metabolism for therapy","volume":"36","author":"O\u2019Sullivan","year":"2015","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.013_bib0785","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/ajcn\/nqz139","article-title":"Dietary quality and the colonic mucosa-associated gut microbiome in humans","volume":"110","author":"Liu","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0790","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2891-3-19","article-title":"Nutrition and cancer: a review of the evidence for an anti-cancer diet","volume":"3","author":"Donaldson","year":"2004","journal-title":"Nutr. J."},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.013_bib0795","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1348-0421.12175","article-title":"Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL","volume":"58","author":"Nami","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.013_bib0800","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/apm.12556","article-title":"Lactobacillus crispatus strain SJ-3C-US induces human dendritic cells (DCs) maturation and confers an anti-inflammatory phenotype to DCs","volume":"124","author":"Eslami","year":"2016","journal-title":"APMIS"},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.013_bib0805","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41575-019-0199-6","article-title":"Author correction: probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl 2","key":"10.1016\/j.semcancer.2021.07.013_bib0810","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/523339","article-title":"Probiotics in the United States","volume":"46","author":"Vanderhoof","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.013_bib0815","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/annonc\/mdu106","article-title":"The efficacy and safety of probiotics in people with cancer: a systematic review","volume":"25","author":"Redman","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0820","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.iotech.2020.05.001","article-title":"Intervention strategies for microbial therapeutics in cancer immunotherapy","volume":"6","author":"Gopalakrishnan","year":"2020","journal-title":"Immuno-Oncol. Technol."},{"key":"10.1016\/j.semcancer.2021.07.013_bib0825","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.2147\/CMAR.S217362","article-title":"Atopobium vaginae and porphyromonas somerae induce proinflammatory cytokines expression in endometrial cells: a possible implication for endometrial cancer?","volume":"11","author":"Caselli","year":"2019","journal-title":"Cancer Manage. Res."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2100208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2100208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:33:21Z","timestamp":1760920401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X2100208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":165,"alternative-id":["S1044579X2100208X"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.013","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbes in gynecologic cancers: Causes or consequences and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}